PerkinElmer
check quantity

AngioSPARK 750 Fluorescent Imaging Agent

Near-infrared (NIR) fluorescent agent for in vivo imaging and other applications.

For laboratory use only. This product is intended for animal research only and not for use in humans.

Part Number
List Price
Your Price
Quantity
NEV10150
836.00 USD
 
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

NanoSPARKS® are a family of highly fluorescent near infrared nanoparticles specifically designed for in vivo imaging. NanoSPARKS contain an iron oxide core that is coated to specifically produce a functionalized biocompatible product. AngioSPARK 750 comprises pegylated fluorescent nanoparticles that remain localized in the vasculature for extended periods of time and enable imaging of blood vessels and angiogenesis. 

AngioSPARK 750 fluorescent imaging agent can also be used at later time points (>12 hours) to image vascular leak in tissue site of inflammation and cancer. AngioSPARK 750 can be imaged within the interstitium for up to 24 hours post tail vein injection.

Specifications

Fluorescent Agent Type Vascular
Optical Imaging Classification Fluorescence Imaging
Quantity in a Package Amount 1.0 Units
Shipping Condition Ambient
Therapeutic Area Vascular disease, Angiogenesis, Atherosclerosis, Arthritis, Inflammation, Oncology/Cancer
Unit Size 1 Vial (5 doses)
Wave Length 750 nm
Resources, Events & More
  • All

Ebook

In Vivo Imaging Solutions eBook

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And our hard-earned expertise makes us a trusted provider of pre-clinical imaging solutions— with more than 9,000 peer reviewed articles as proof.

PDF 4 MB

Flyer

Technical Note

AngioSPARK® 750 NanoSPARK™ (Data Sheet)

NanoSPARKS™ are a new family of highly fluorescent near infrared nanoparticles specifically designed for in vivo imaging. NanoSPARKS contain an iron oxide core that is coated to specifically produce a functionalized biocompatible product. AngioSPARK® 750 comprises pegylated fluorescent nanoparticles that remain localized in the vasculature for extended periods of time and enable imaging of blood vessels and angiogenesis.

PDF 49 KB

White Paper

The Role of In Vivo Imaging in Drug Discovery and Development

The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick and efficient drug screening and evaluation. Read this White Paper to learn how preclinical in vivo imaging helps to ensure that smart choices are made by providing Go/No-Go decisions and de-risking drug candidates early on, significantly reducing time to the clinic and lowering costs all while maximizing biological understanding.

PDF 748 KB